Fusion Antibodies pleased with progress in first half
22nd Oct 2019 15:13
(Sharecast News) - Preclinical antibody discovery company Fusion Antibodies updated the market on the six months ended 30 September on Tuesday, reporting continued revenue growth amid the commercial roll out of new services.
Read moreFusion Antibodies revenues soar in strong second half
17th Apr 2019 10:46
(Sharecast News) - Pharmaceutical research outfit Fusion Antibodies reported a strong second half on Wednesday, driven by a significant increase in orders.
Read moreFusion Antibodies dives as revenues falter
25th Feb 2019 10:43
(Sharecast News) - Fusion Antibodies' shares plummeted on Monday after the company warned of failing revenues due to uncertainty surrounding the timing of "a number of potential substantial orders".
Read moreFusion Antibodies launches new 'RAMP' platform
17th Dec 2018 14:51
(Sharecast News) - Pharmaceutical contract research organisation Fusion Antibodies launched its new 'Rational Affinity Maturation Platform' (RAMP) at the Antibody Engineering Conference in San Diego last week, it announced on Monday.
Read moreFusion Antibodies sees losses widen throughout 'challenging' first half
26th Nov 2018 10:17
(Sharecast News) - Pharmaceutical research outfit Fusion Antibodies saw losses widen sharply throughout the first half of its trading year after revenues more than halved.
Read moreFusion Antibodies gets dragged to a loss as non-recurring items skyrocket
16th Aug 2018 08:10
(Sharecast News) - Contract researcher Fusion Antibodies saw revenues hit £2.7m in its last trading year but was unable to chalk up a profit.
Read moreFusion Antibodies gets dragged to a loss as non-recurring items skyrocket
16th Aug 2018 08:10
(Sharecast News) - Contract researcher Fusion Antibodies saw revenues hit £2.7m in its last trading year but was unable to chalk up a profit.
Read moreFusion Antibodies shares tumble following downbeat outlook
13th Aug 2018 08:27
(Sharecast News) - Fusion Antibodies shares crashed on Monday morning after the Belfast-based researcher revealed that year-to-date trading had been "slower than anticipated".
Read more